Dianna S. Howard, MD
- Professor, Hematology and Oncology

Dianna S. Howard, MD
Research Interests
- Effective Aging on Transplants
- Quality Outcomes
- AYA Patient Experience
- Education
- BA, Transylvania University, 1986
- MD, University of Kentucky, 1991
- Residency
- University of Kentucky Hospital, 1998
- Board Certifications
- American Board of Internal Medicine, Hematology
- Positions
- Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia. Pardee TS, Anderson RG, Pladna KM, Isom S, Ghiraldeli LP, Miller LD, Chou JW, Jin G, Zhang W, Ellis LR, Berenzon D, Howard DS, Hurd DD, Manuel M, Dralle S, Lyerly S, Powell BL. Clin Cancer Res. 2018 05; 24(9):2060-2073.
- Simultaneous quantitation of oxidized and reduced glutathione via LC-MS/MS: An insight into the redox state of hematopoietic stem cells. Carroll D, Howard D, Zhu H, Paumi CM, Vore M, Bondada S, Liang Y, Wang C, St Clair DK. Free Radic. Biol. Med. 2016 08; 97:85-94.
- Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia. Malik M, Chiles J, Xi HS, Medway C, Simpson J, Potluri S, Howard D, Liang Y, Paumi CM, Mukherjee S, Crane P, Younkin S, Fardo DW, Estus S. Hum. Mol. Genet. 2015 Jun; 24(12):3557-70.
- A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: a report from the Children's Oncology Group. Horton TM, Perentesis JP, Gamis AS, Alonzo TA, Gerbing RB, Ballard J, Adlard K, Howard DS, Smith FO, Jenkins G, Kelder A, Schuurhuis GJ, Moscow JA. Pediatr Blood Cancer. 2014 Oct; 61(10):1754-60.